Diane-35 & Breastfeeding: Contraindicated – Risks & Safer Alternatives
Diane-35 (cyproterone acetate + ethinyl estradiol) is contraindicated during breastfeeding.
Risks to Infant
- Hepatotoxicity: Cyproterone associated with jaundice, hepatitis, liver failure in neonates.
- Hormonal effects: Estrogen suppresses prolactin → reduces milk supply; anti-androgen may affect infant development.
- Thromboembolism: Combined OCs increase maternal VTE risk postpartum.
Safer Contraceptive Options for Breastfeeding
| Method | Safety | Timing |
|---|---|---|
| Progestin-only pill (minipill) | Preferred | Immediately postpartum |
| Hormonal IUD (levonorgestrel) | Preferred | ≥4 weeks postpartum |
| Copper IUD | Preferred | Immediate or ≥4 weeks |
| Implant (etonogestrel) | Preferred | Immediately postpartum |
| DMPA injection | Preferred | Immediately postpartum |
| Barrier methods | Compatible | Anytime |
Combined estrogen-progestin methods (pill, patch, ring) generally avoided <6 weeks postpartum due to VTE risk and milk supply impact.
Discuss individualized plan with OB/GYN or midwife.
Breast Reduction - Related Articles
- MonaVie & Breastfeeding: Safety Review of Ingredients
- How to Remove a Bra and Underwear: Practical Steps
- Understanding the Taste of Breast Milk: Factors, Variations & Infant Acceptance
- Persistent Cramps & Breast Tenderness Without Period: Causes & Action Plan
- Chest Development in Preteens: Healthy Approaches and When to Seek Advice
- Breastfeeding Conflict: When Mom Wants to Stop but Toddler Doesn't
- Breastfeeding Guide: Benefits, Technique, Troubleshooting & Weaning